What is the recommended treatment for erectile dysfunction using Viagra (sildenafil)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sildenafil (Viagra) for Erectile Dysfunction

First-Line Treatment Recommendation

Initiate sildenafil as first-line therapy for erectile dysfunction at a starting dose of 50 mg taken approximately 1 hour before sexual activity, with dose adjustment to 25-100 mg based on efficacy and tolerability, taken no more than once daily. 1, 2

Dosing Strategy

Starting Dose and Titration

  • Begin with 50 mg taken 1 hour before sexual activity as the standard starting dose 1, 3
  • Adjust to 100 mg if 50 mg provides insufficient response, or reduce to 25 mg if side effects are problematic 1, 3
  • Maximum frequency is once daily 2
  • Sildenafil shows dose-related improvement from 25 mg to 50 mg, but less additional benefit when increasing from 50 mg to 100 mg 2, 4

Alternative Approach: Starting at 100 mg

  • Starting directly at 100 mg is safe and may reduce anxiety about sexual performance—56% of men felt no anxiety about the next intercourse attempt with 100 mg vs 39% with 50 mg 5
  • The 100 mg starting dose improves treatment satisfaction and sexual experience compared to 50 mg, with no increase in adverse events 5

Adequate Trial Before Declaring Failure

  • Ensure 4-8 attempts at proper dosing before declaring treatment failure 2
  • Before switching therapies, verify: adequate sexual stimulation, proper timing (1 hour before activity), absence of excessive alcohol, no interfering medications, and relationship factors 4, 6

Efficacy Across Populations

General Population

  • 69% success rate for sexual intercourse with sildenafil vs 35.5% with placebo 2
  • 73-88% of patients report improved erections vs 26-32% with placebo 2, 4

Special Populations

  • Diabetes: 56% of men with diabetes reported improved erections vs 10% with placebo, though response is less robust than in the general population 2, 7
  • Cardiovascular disease/hypertension: 71% response rate vs 27% with placebo 8
  • Depression: 78% response rate vs 29% with placebo 8
  • Post-prostatectomy: Effective but with diminished response compared to general ED population 2
  • Age: Efficacy is maintained regardless of age (<45,46-64, ≥65 years), though older patients may require lower starting doses (25 mg) 3, 8

Critical Safety Considerations

Absolute Contraindications

  • Never prescribe sildenafil with nitrates—this combination causes potentially fatal hypotension 1, 2, 9
  • Nitrates include: nitroglycerin (any form), isosorbide mononitrate/dinitrate, and "poppers" (amyl nitrate/nitrite) 9
  • If emergency nitrate administration is required, wait at least 24 hours after sildenafil use before giving nitrates 2, 6

Cardiovascular Risk Assessment

  • Most ED patients fall into low-risk category and can safely receive sildenafil, including those with: asymptomatic CAD with <3 risk factors, controlled hypertension, mild stable angina, successful coronary revascularization, uncomplicated past MI, mild valvular disease, and CHF (NYHA class I) 6
  • Refer to cardiology before prescribing if cardiovascular risk is indeterminate or patient cannot perform moderate physical activity 6

Dose Adjustments for Special Circumstances

  • Reduce to 25 mg in elderly patients, those with hepatic or renal impairment, or those receiving CYP3A4 inhibitors (ritonavir, ketoconazole, erythromycin, cimetidine) 3
  • Severe hepatic impairment: PDE5 inhibitors generally not recommended 6

Adverse Effects Profile

Common Side Effects (Mild to Moderate)

  • Headache (11%), flushing, dyspepsia (9%), nasal congestion (6%), visual disturbances, myalgia, dizziness 1, 4, 3, 7
  • Serious adverse events occur in <2% of patients, with no significant difference compared to placebo 4

Rare but Serious Events

  • Sudden vision loss (NAION): Advise patients to seek immediate medical attention for sudden loss of vision in one or both eyes 9
  • Sudden hearing loss: May be accompanied by tinnitus and dizziness; requires prompt medical attention 9
  • Cardiovascular events in postmarketing surveillance generally occurred in patients with other known risk factors 3

Mechanism and Patient Education

How Sildenafil Works

  • Selectively inhibits phosphodiesterase type 5 (PDE5), allowing corpus cavernosum smooth muscle to relax and potentiating erections during sexual stimulation 3
  • Sexual stimulation is necessary for the medication to work—sildenafil does not cause automatic erections 4, 6

Pharmacokinetics

  • Rapidly absorbed with peak plasma concentrations within 1 hour 3
  • Elimination half-life is 3-5 hours 3
  • Food may delay absorption, so taking on an empty stomach may improve onset 3

Comparison with Other PDE5 Inhibitors

Sildenafil vs Tadalafil

  • Both are equally effective first-line treatments (69% success rate for both) 2
  • Primary difference: tadalafil has longer duration of action (up to 36 hours vs 4-5 hours for sildenafil) 2
  • Choose based on patient preference: sildenafil for planned sexual activity, tadalafil for spontaneity or daily dosing option 1, 2
  • Cost, ease of use, and adverse effects profile should guide selection when efficacy is equivalent 1

Combination Therapy Considerations

Testosterone Deficiency

  • For men with ED and testosterone deficiency, combining sildenafil with testosterone therapy may be more effective than sildenafil alone 6
  • Testosterone therapy alone is not effective monotherapy for ED 6
  • Check total testosterone, free testosterone, and SHBG if response to sildenafil is suboptimal 6

Benign Prostatic Hyperplasia (BPH)

  • If treating both ED and BPH, consider switching to tadalafil 5 mg daily, which treats both conditions simultaneously (FDA-approved indication) 6
  • Avoid combining sildenafil with alpha-blockers for BPH, as this offers no advantage and increases hypotension risk 6

Ongoing Management

Follow-Up Assessment

  • Periodically assess efficacy, side effects, and changes in health status or medications 4, 6
  • Verify cardiovascular health hasn't changed 6
  • Review new medications for potential interactions 6
  • Confirm proper use: timing, sexual stimulation, alcohol consumption, relationship factors 4, 6

When to Switch Therapies

  • If inadequate response after 4-8 attempts at maximum dose, consider switching to a different PDE5 inhibitor (vardenafil or tadalafil) 2, 6
  • Address modifiable factors before switching: hormonal abnormalities, drug interactions, timing issues, inadequate sexual stimulation, excessive alcohol, relationship problems 4, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.